Brenda Libby Coleman

Array ( [id] => 5102061 [patent_doc_number] => 20070185323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Method of preparing benzazepines and derivatives thereof' [patent_app_type] => utility [patent_app_number] => 10/591175 [patent_app_country] => US [patent_app_date] => 2005-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13956 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185323.pdf [firstpage_image] =>[orig_patent_app_number] => 10591175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4572417 [patent_doc_number] => 07858779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Process for preparing oxcarbazepine' [patent_app_type] => utility [patent_app_number] => 10/580145 [patent_app_country] => US [patent_app_date] => 2005-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1421 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858779.pdf [firstpage_image] =>[orig_patent_app_number] => 10580145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644457 [patent_doc_number] => 08022062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => '6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/598302 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 163414 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022062.pdf [firstpage_image] =>[orig_patent_app_number] => 10598302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739052 [patent_doc_number] => 20060009443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/060560 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20007 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009443.pdf [firstpage_image] =>[orig_patent_app_number] => 11060560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101833 [patent_doc_number] => 20070185095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/588699 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19940 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185095.pdf [firstpage_image] =>[orig_patent_app_number] => 10588699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314869 [patent_doc_number] => 07524839 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Compounds, their use and preparation' [patent_app_type] => utility [patent_app_number] => 11/057033 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20912 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524839.pdf [firstpage_image] =>[orig_patent_app_number] => 11057033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912960 [patent_doc_number] => 20050176718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/056412 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94672 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176718.pdf [firstpage_image] =>[orig_patent_app_number] => 11056412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42842 [patent_doc_number] => 07781425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Guanidine compound and asymmetric reaction using the same' [patent_app_type] => utility [patent_app_number] => 10/589814 [patent_app_country] => US [patent_app_date] => 2005-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14752 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781425.pdf [firstpage_image] =>[orig_patent_app_number] => 10589814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250525 [patent_doc_number] => 20050272720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Process for making olanzapine Form I' [patent_app_type] => utility [patent_app_number] => 11/050851 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3632 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272720.pdf [firstpage_image] =>[orig_patent_app_number] => 11050851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771648 [patent_doc_number] => 20050267099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Synthesis of olanzapine and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 11/050850 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3026 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267099.pdf [firstpage_image] =>[orig_patent_app_number] => 11050850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250531 [patent_doc_number] => 20050272721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Stable salts of olanzapine' [patent_app_type] => utility [patent_app_number] => 11/050852 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8035 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272721.pdf [firstpage_image] =>[orig_patent_app_number] => 11050852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442902 [patent_doc_number] => 07928224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same' [patent_app_type] => utility [patent_app_number] => 10/587467 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49003 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928224.pdf [firstpage_image] =>[orig_patent_app_number] => 10587467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887892 [patent_doc_number] => 20080262224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide' [patent_app_type] => utility [patent_app_number] => 10/597251 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11632 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262224.pdf [firstpage_image] =>[orig_patent_app_number] => 10597251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291187 [patent_doc_number] => 20090023917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms' [patent_app_type] => utility [patent_app_number] => 10/597241 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37945 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023917.pdf [firstpage_image] =>[orig_patent_app_number] => 10597241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040546 [patent_doc_number] => 20050159408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods of synthesizing olanzapine' [patent_app_type] => utility [patent_app_number] => 11/020869 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3048 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159408.pdf [firstpage_image] =>[orig_patent_app_number] => 11020869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285532 [patent_doc_number] => 07550459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Tetrahydroquinoline analogues as muscarinic agonists' [patent_app_type] => utility [patent_app_number] => 11/019556 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89999 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550459.pdf [firstpage_image] =>[orig_patent_app_number] => 11019556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7188037 [patent_doc_number] => 20050192268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders' [patent_app_type] => utility [patent_app_number] => 11/019555 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32398 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192268.pdf [firstpage_image] =>[orig_patent_app_number] => 11019555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688976 [patent_doc_number] => 20060287291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 11/018019 [patent_app_country] => US [patent_app_date] => 2004-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62188 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287291.pdf [firstpage_image] =>[orig_patent_app_number] => 11018019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586022 [patent_doc_number] => 20090105224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor' [patent_app_type] => utility [patent_app_number] => 10/583590 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19798 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105224.pdf [firstpage_image] =>[orig_patent_app_number] => 10583590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057644 [patent_doc_number] => 20070060566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Benzazepine derivatives as histamine h3 antagonists' [patent_app_type] => utility [patent_app_number] => 10/596503 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22527 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060566.pdf [firstpage_image] =>[orig_patent_app_number] => 10596503 [rel_patent_id] =>[rel_patent_doc_number] =>)